Myocardial Injury for COVID-19 Even in Young Patients with Mild Symptoms

Most young COVID-19 patients not requiring hospitalization showed abnormal cardiac magnetic resonance imaging (CMR) beyond two months after diagnosis.

Injuria miocárdica por COVID-19 incluso en jóvenes y con síntomas leves

Myocardial injury had been found in more serious cases, but not in a healthy population recovered at home.

The increasing evidence of the virus’ capacity to directly affect the heart across the whole population and disease severity spectrum turns our previous article published on March 3 obsolete. In only 5 months, we went from denying myocarditis to saying it is frequent, and that it might even be the norm.

78% of patients in a center in Germany showed abnormal CMR findings 2 to 3 months after testing positive for COVID 19 and despite the fact that 67% of these patients never required hospitalization.


Read also: Infarction, Stroke and Aortic Emergency Syndromes in the Shadow of the Pandemic.


Conventional CMR sequences were used to assess cardiac function, volume, myocardial mass and scars in addition to myocardial mapping in T1 and T2.

The study included 100 patients recovering from the infection (mean age 49) who received high-sensitivity troponin T and CMR testing. A few patients in the group presented traditional risk factors, but only one third was hospitalized and only 2 required mechanical ventilation.

In most patients (78%) troponin was detected at CMR time, even though it had been between 64 and 92 days after diagnosis.


Read also: Temporary Emergency Guidelines for Infarction During the Pandemic.


The publication of this study in JAMA Cardiology has raised many questions that remain unanswered. What should we do with these findings and how long will they persist? Is it necessary to take cardio-protection measures of some kind, with anti-inflammatory or cardiac failure medication?

The answers will come from centers that have already fought the first wave while the rest of us weather the storm.

Original Title: Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19).

Reference: Puntmann VO et al. JAMA Cardiol. 2020; Epub ahead of print.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Plaque Ruptures in Non-Culprit Arteries: Follow-Up With Intravascular Imaging

Plaque rupture remains one of the most important pathophysiological mechanisms in acute coronary syndromes. However, not all ruptures manifest clinically as ischemia, myocardial infarction,...

OCT-Detected High-Risk Plaques Predict Recurrent Events After Myocardial Infarction

After a myocardial infarction (MI), non-culprit lesions are often deferred when they are not flow-limiting (negative FFR). However, these lesions continue to represent an...

Ticagrelor vs Clopidogrel in ACS Patients Receiving DOAC After PCI: More Bleeding Without Ischemic Benefit?

In patients with acute coronary syndrome (ACS) who require direct oral anticoagulation (DOAC) and undergo percutaneous coronary intervention (PCI), current guidelines recommend a dual...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Inflammation after TAVI: An Emerging Therapeutic Target?

Conduction disturbances and the need for permanent pacemaker implantation remain common complications following TAVI, with an incidence approaching 15%. Although they have traditionally been...

SPYRAL Program: 3-Year Outcomes in Patients Treated with Renal Denervation

Hypertension is the leading modifiable risk factor for cardiovascular disease and remains a major global health challenge, affecting more than one billion adults worldwide.  Despite...

Coronary Obstruction During TAVI: A New Volumetric Index to Consider

Coronary obstruction during TAVI is an uncommon but potentially catastrophic complication, particularly in valve-in-valve procedures, in anatomies with small sinuses of Valsalva, low coronary...